2015
DOI: 10.1007/s11999-015-4298-6
|View full text |Cite
|
Sign up to set email alerts
|

From Bench to Bedside: It's Cold in There—Isn't It Time We Gave Our Implants a Coat?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 12 publications
(11 reference statements)
0
2
0
Order By: Relevance
“…Berend and colleagues [2] reported only a 14% infection rate with this approach following nononcologic total femur replacement; additional study is necessary to demonstrate efficacy and, furthermore, safety of this approach. Implant coatings-silver, betadine, antibiotic-represent another opportunity, but none are currently in broad clinical use [8].…”
Section: How Do We Get There?mentioning
confidence: 99%
“…Berend and colleagues [2] reported only a 14% infection rate with this approach following nononcologic total femur replacement; additional study is necessary to demonstrate efficacy and, furthermore, safety of this approach. Implant coatings-silver, betadine, antibiotic-represent another opportunity, but none are currently in broad clinical use [8].…”
Section: How Do We Get There?mentioning
confidence: 99%
“…ir William Arbuthnot Lane is widely credited with the first routine use of metallic implants for internal fixation fractures, starting in 1892 [1]. As I have previously suggested in this column [8,9], orthopaedic implants and fixation techniques have evolved in the intervening 130 years. However, most internal fixation devices still are metallic and usually made of titanium or stainless steel.…”
mentioning
confidence: 99%